ISRCTN39679215已完成3 期
A Phase III Randomised comparison of Gemcitabine/Carboplatin with Cisplatin/Etoposide in Small Cell Lung Cancer
CRI CSG and London Lung Cancer Group (UK)0 个研究点目标入组 241 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 241
研究概览
简要总结
2001 Results article in http://www.ncbi.nlm.nih.gov/pubmed/11510029 results
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically or cytologically proven small cell anaplastic carcinoma of the lung
- •2. Extensive stage disease or limited stage but locally advanced or limited stage with poor prognostic factors
- •3. Measurable or evaluable disease
- •4. Adequate renal function for chemotherapy
- •5. Age 18 years or above
- •6. Adequate contraception for women of child bearing potential
- •7. Written informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
3 期
A Phase III randomised comparison of Gemcitabine/Carboplatin with Mitomycin, Ifosfamide and Cisplatin in non-small cell lung cancerung (non-small cell) cancerMalignant neoplasm of bronchus and lungCancerISRCTN52253218ondon Lung Cancer Group (UK)422
已完成
3 期
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary SiteNeoplasms, Unknown PrimaryNCT00193596SCRI Development Innovations, LLC198
招募中
不适用
Gemzar studyCancerPACTR201510001143243AMPATH Oncology Institute70
已完成
2 期
Randomized phase II study comparing Gemcitabine chemoradiotherapy with Gemcitabine chemotherapy for unresectable locally advanced pancreatic cancer.nresectable locally advanced pancreatic cancer.JPRN-UMIN000012253Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology110
已完成
3 期
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract CancerBiliary Tract CancerNCT02182778Kansai Hepatobiliary Oncology Group246